STADA securities

The Executive Board is authorized, in accordance with the resolution adopted by the Shareholders' Meeting on June 10, 2008, with the approval of the Supervisory Board, to increase the share capital of the company on one or more occasions by 10 June 2013 by up to EUR 76,346,010.00 through the issue of up to 29,363,850 registered shares with restricted transferability against contributions in cash and/or in kind. Shareholders are to be granted subscription rights. The Executive Board shall nevertheless be authorised, with the approval of the Supervisory Board, to exclude the statutory subscription rights of the shareholders in specific cases.

Click here for further details!

For information regarding the previous authorized capital click here!

Issued capital stock to be increased from the company's own funds

In accordance with the resolution adopted by the Shareholders' Meeting in June 2004, the Executive Board was authorized to increase the company's issued capital stock from its own funds.

The de facto 1:1 stock split was carried out once this resolution had been entered in the commercial trade register after the close of trading on July 30, 2004.

• Annual Shareholders' Meeting resolution of June 15, 2004 (available in German only)
• Ad hoc release of July 28, 2004:
  STADA to carry out de facto 1:1 stock split after close of trading on 07/30/2004
• Official announcement to the STADA shareholders concerning the increase in the company's issued capital stock from existing funds and request to collect bonus shares
• First warning of the sale of unclaimed shares of August 2005
• Second warning of the sale of unclaimed shares of September 2005
• Third and final warning of the sale of unclaimed shares of October 2005
• Upcoming sale of unclaimed shares of October 2006

In accordance with the resolution adopted by the Shareholders' Meeting on June 10, 2009, the company is authorized to purchase treasury shares to a value of up to 10% of the company's share capital on or before December 10, 2010.

Click here for further details

As of December 31, 2008, STADA held 109,659 of its own shares, compared to 114,351 shares which the company had held as of December 31, 2007. In 2008 STADA – exclusively in the context of executing an employee stock ownership program based on a company agreement in Germany – purchased 127 of its own shares at an average price of EUR 45.65 and sold 4,819 of its own shares at an average price of EUR 32.90. In the first three quarters of 2009 STADA did not purchase any treasury shares and sold 5,392 treasury shares at an average price of EUR 13.87. As of September 30, 2009, 104,267 treasury shares were thereby held by STADA, compared to 109,659 treasury shares which the Company had held as of December 31, 2008.

As of September 30, 2009 181,520 STADA warrants 00/6-26-15 were on the official market.

• Option terms and conditions* for STADA 00/26.06.15 warrants (PDF)
• Official announcement to holders of STADA warrants of September 2000
• Official announcement to holders of STADA warrants of October 2003
• Official announcement to holders of STADA warrants of July 2004
• Official announcement to holders of STADA warrants of June 2005

*Sales prospectus / stock exchange listing prospectus from 2000

Until June 2005, 75,000 partial debentures of EUR 1,000.- each were approved for official trading. The bonds were traded both with (cum; ISIN DE0001069540) and without (ex; ISIN DE0001069557) warrants attached. In accordance with the bond terms and conditions (available in German only), the partial debentures were repaid on June 26, 2005 (“due date”) at the nominal value (EUR 1,000.-). With those bonds that had been traded with warrants attached (cum), the warrants were automatically separated from the bond so that following repayment of the bond the respective number of warrants in the depot remained.

The Executive Board is authorized, in accordance with the resolution adopted by the Shareholders' Meeting on June 10, 2008, on or before 9 June 2013, on one or more occasions,

• to issue bonds with warrants and/or convertible bonds in an aggregate nominal amount of up to EUR 1,000,000,000.00 and with a maturity of up to 20 years through the company or through companies in which the company directly or indirectly has a majority holding, and
• to assume the guarantee for such bonds with warrants and/or convertible bonds issued by subordinated group companies of the company

and to grant the holders or creditors of bonds with warrants and/or convertible bonds, option and/or conversion rights up to a total of 25,701,330 registered shares with restricted transferability of the company, representing a proportionate amount of the share capital of up to EUR 66,823,458.00 in accordance with the more detailed provisions of the respective terms of the bonds with warrants and/or convertible bonds.

Click here for further details!

Please click here for information about the disclosure requirements in accordance with § 15a WpHG.

STADA Arzneimittel AG
Corporate Communications
Stadastrasse 2-18
D-61118 Bad Vilbel
Phone: +49 6101 603-113
Fax: +49 6101 603-506
e-mail: communications@stada.de